10 immunotherapy companies making waves in 2023
Immunotherapy has been widely studied in cancer treatment research, ever since William Coley, who is…
Immunotherapy has been widely studied in cancer treatment research, ever since William Coley, who is…
A new study shows antibiotic treatment prior to CAR-T cell therapy is connected to unfavorable…
AELIX Therapeutics S.L., a clinical-stage biotechnology company specializing in the discovery and development of immunotherapies…
Cytovation ASA, a Norwegian clinical stage immune-oncology company focused on the development of CyPep-1, its…
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, has closed its €22 million…
Mnemo Therapeutics, a French biotechnology company developing immunotherapies, has announced publication of two scientific studies…
By Ian B. Walters, chief executive officer and chairman, Portage Biotech In recent years, PD-1/PD-L1…
In our body, we have an innate immune system and an immune system that is…
A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed)…
Brenus Pharma and InSphero AG have received a €1.5 million grant for the collaborative project…
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU…
Valo Therapeutics Oy is a Finnish immunotherapy company developing antigen-coated oncolytic viruses and vaccine vectors…